| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 275.24B | 275.24B | 254.45B | 242.29B | 226.95B | 195.93B |
| Gross Profit | 35.35B | 35.35B | 32.09B | 29.70B | 27.57B | 25.25B |
| EBITDA | 13.40B | 13.40B | 12.15B | 11.14B | 10.28B | 8.92B |
| Net Income | 8.10B | 8.10B | 7.37B | 6.29B | 5.84B | 5.01B |
Balance Sheet | ||||||
| Total Assets | 77.10B | 77.10B | 69.83B | 68.99B | 64.17B | 59.27B |
| Cash, Cash Equivalents and Short-Term Investments | 15.28B | 15.28B | 11.14B | 15.23B | 11.05B | 12.18B |
| Total Debt | 8.17B | 8.17B | 8.27B | 8.88B | 9.04B | 10.13B |
| Total Liabilities | 47.94B | 47.94B | 46.21B | 43.94B | 43.52B | 41.19B |
| Stockholders Equity | 29.16B | 29.16B | 23.62B | 25.06B | 20.64B | 17.56B |
Cash Flow | ||||||
| Free Cash Flow | 7.84B | 7.84B | 6.63B | 6.75B | 3.50B | 5.37B |
| Operating Cash Flow | 13.34B | 13.34B | 11.34B | 11.07B | 7.39B | 8.96B |
| Investing Cash Flow | -5.31B | -5.31B | -4.41B | -4.97B | -4.76B | -3.54B |
| Financing Cash Flow | -3.77B | -3.77B | -10.76B | -2.61B | -3.44B | -6.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $869.84B | 38.22 | 24.87% | 0.84% | 4.34% | 17.27% | |
73 Outperform | $23.94B | 20.12 | 15.60% | 2.17% | 4.98% | -15.98% | |
72 Outperform | $40.81B | 10.90 | 25.09% | 5.03% | -2.16% | -12.66% | |
71 Outperform | $11.96B | 20.92 | 29.24% | ― | 2.82% | 3.77% | |
68 Neutral | $402.52B | 49.88 | 30.69% | 0.56% | 8.17% | 9.92% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | $22.39B | ― | 20.07% | ― | -29.67% | -178.03% |